Divalproex ER prophylaxis in migraineurs with probable chronic migraine and probable medication-overuse headache: A case series

Pain Practice

Volumn 4, Issue 4, 2004, Pages 292-294

  Landy, Stephen H ^a   Baker, Jeffrey D ^b  

^a Wesley Headache Clinic   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Divalproex ER; Migraine; Probable chronic; Prophylaxis

Indexed keywords

VALPROATE SEMISODIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEADACHE; HUMAN; MIGRAINE; PATIENT SATISFACTION; TRANSFORMED MIGRAINE;

EID: 18244370750     PISSN: 15307085     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2004.04404.x     Document Type: Article

References (9)

1. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004;24(suppl 1):1-160.
2. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - Current understanding and treatment. N Engl J Med. 2002; 346: 257-270.
3. Castillo J, Munoz P, Guitera V, et al. Epidemiology of chronic daily headache in the general population. Headache. 1999;39: 190-196.
4. Mathew NT. Transformed migraine. Cephalalgia. 1993;13(suppl 12):78-83.
5. Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, Taffi R, Provinciali L. Topiramate in the treatment of chronic migraine. Cephalalgia. 2003;23: 820-824.
6. Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex. Arch Neurol. 1995; 52: 281-286.
7. Klapper J. Divalproex Sodium Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: a dose controlled study. Cephalalgia. 1997;17: 103-108.
8. Landy SH, McGinnis J. Divalproex sodium-review of prophylactic migraine efficacy, safety and dosage, with recommendations. Tenn Med. 1999;92: 135-136.
9. Freitag FG, Collins SD, Carlson HA, et al. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology. 2002;58: 1652-1659.